Search Results - Mark Lambton
- Showing 1 - 1 results of 1
-
1
Cost per response analysis of deucravacitinib versus apremilast and first-line biologics among patients with moderate to severe plaque psoriasis in the United States by Sang Hee Park, Mark Lambton, Jordana Schmier, Sara Hovland, Keith Wittstock, Vardhaman Patel
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book